Literature DB >> 19143649

Prolyl hydroxylases as regulators of cell metabolism.

Houda Boulahbel1, Raúl V Durán, Eyal Gottlieb.   

Abstract

Cellular response to oxygen depletion is mediated by HIF (hypoxia-inducible factor). HIF is a heterodimer consisting of a constitutively expressed subunit (HIFbeta) and an oxygen-regulated subunit (HIFalpha). HIFalpha stability is regulated by prolyl hydroxylation by PHD (prolyl hydroxylase domain-containing protein) family members. PHD activity depends on the availability of molecular oxygen, making PHDs the oxygen-sensing system in animal cells. However, PHDs have recently been shown to respond to stimuli other than oxygen, such as 2-oxoglutarate (alpha-ketoglutarate), succinate or fumarate, as illustrated by the pseudo-hypoxic response in succinate dehydrogenase- or fumarate dehydrogenase-deficient tumours. Moreover, HIFalpha is not the sole PHD effector, suggesting that PHDs have functions that extend beyond oxygen sensing. Currently, we are investigating the role of PHDs in the cellular response to amino acid deprivation, a process regulated by mTOR (mammalian target of rapamycin). The precise mechanism whereby amino acids are signalling to mTOR is not fully understood. Given that 2-oxoglutarate is a limiting co-substrate for PHD activity during normoxia and that 2-oxoglutarate levels depend on amino acid availability, it is possible that PHD activity depends not only on oxygen, but also on amino acid availability, suggesting a global metabolic sensor function for PHDs which could be signalling not only to HIF, but also to mTOR.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19143649     DOI: 10.1042/BST0370291

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  37 in total

Review 1.  Tumor cell metabolism: an integral view.

Authors:  Susana Romero-Garcia; Jose Sullivan Lopez-Gonzalez; José Luis Báez-Viveros; Dolores Aguilar-Cazares; Heriberto Prado-Garcia
Journal:  Cancer Biol Ther       Date:  2011-12-01       Impact factor: 4.742

2.  Guest editorial: hypoxia biology in health and disease.

Authors:  Nobuhito Goda
Journal:  Int J Hematol       Date:  2012-05-02       Impact factor: 2.490

Review 3.  Post-translational modifications in signal integration.

Authors:  Yonathan Lissanu Deribe; Tony Pawson; Ivan Dikic
Journal:  Nat Struct Mol Biol       Date:  2010-05-23       Impact factor: 15.369

Review 4.  Sirtuins and the Metabolic Hurdles in Cancer.

Authors:  Natalie J German; Marcia C Haigis
Journal:  Curr Biol       Date:  2015-06-29       Impact factor: 10.834

5.  Multiomic Profiling of Tyrosine Kinase Inhibitor-Resistant K562 Cells Suggests Metabolic Reprogramming To Promote Cell Survival.

Authors:  Brett M Noel; Steven B Ouellette; Laura Marholz; Deborah Dickey; Connor Navis; Tzu-Yi Yang; Vinh Nguyen; Sarah J Parker; David Bernlohr; Zohar Sachs; Laurie L Parker
Journal:  J Proteome Res       Date:  2019-02-21       Impact factor: 4.466

6.  Extended ischemia prevents HIF1alpha degradation at reoxygenation by impairing prolyl-hydroxylation: role of Krebs cycle metabolites.

Authors:  Anna Serra-Pérez; Anna M Planas; Analía Núñez-O'Mara; Edurne Berra; Judit García-Villoria; Antònia Ribes; Tomàs Santalucía
Journal:  J Biol Chem       Date:  2010-04-05       Impact factor: 5.157

7.  Gerometabolites: the pseudohypoxic aging side of cancer oncometabolites.

Authors:  Javier A Menendez; Tomás Alarcón; Jorge Joven
Journal:  Cell Cycle       Date:  2014-02-03       Impact factor: 4.534

Review 8.  mTOR: dissecting regulation and mechanism of action to understand human disease.

Authors:  Deborah C I Goberdhan; C A Richard Boyd
Journal:  Biochem Soc Trans       Date:  2009-02       Impact factor: 5.407

Review 9.  Hypoxia and hypoxia-inducible factors as regulators of T cell development, differentiation, and function.

Authors:  Eóin N McNamee; Darlynn Korns Johnson; Dirk Homann; Eric T Clambey
Journal:  Immunol Res       Date:  2013-03       Impact factor: 2.829

Review 10.  Hypoxia-inducible factor prolyl hydroxylases as targets for neuroprotection by "antioxidant" metal chelators: From ferroptosis to stroke.

Authors:  Rachel E Speer; Saravanan S Karuppagounder; Manuela Basso; Sama F Sleiman; Amit Kumar; David Brand; Natalya Smirnova; Irina Gazaryan; Soah J Khim; Rajiv R Ratan
Journal:  Free Radic Biol Med       Date:  2013-01-31       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.